To Increase Patient Access

January 20, 2023

New cell therapy engineered to kill and prevent brain cancer in advanced mouse model

Scientists at Brigham and Women’s Hospital are harnessing a new way to turn cancer cells into potent, anti-cancer agents. Khalid Shah and his team of Harvard-affiliated researchers have developed a new cancer-killing vaccine. This new cell therapy can be used to treat existing tumors and prevent recurrences. They have achieved promising results when applying this treatment to a mouse-model of glioblastoma.

Brain scan images

"Our team has pursued
a simple idea: to take
cancer cells and
transform them into
cancer killers and vaccines."

— Khalid Shah


Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
corporate partners
upcoming events
About us
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram